Shen, Yitong I.
Nelson, Andrew J.
Oberlin, Brandon G.
Funding for this research was provided by:
Indiana Clinical and Translational Sciences Institute (UL1TR001108)
Article History
Received: 9 July 2022
Accepted: 17 August 2022
First Online: 15 September 2022
Declarations
:
: Dr. Oberlin and Mr. Nelson, founders of Relate XR, LLC, an STTR NIH applicant, are inventors of a patent filed by Indiana University on the technology described in the manuscript.
: All study procedures were approved by the Indiana University Institutional Review Board. We obtained informed consent from 34 participants, with 13 of those later disqualified.